The outbreak of yet another row over the funding of embryonic stem cell research looks likely this week when MEPs debate the Horizon 2020 proposals.
There are bound to be divergent views expressed at hearings on Monday and Tuesday on the precise size and shape of the proposed €80 billion Horizon 2020 R&D programme, which succeeds Framework Programme 7 in 2014. But these will merely represent differing opinions on how to achieve the shared objective of...
This page requires a Science|Business Network Membership
This page is available to Science|Business Network Members only. If you are already a member then please log in (above).
Note if you are only registered to receive our Bulletin, or have previously purchased an item from our store, this does not give you access to the full benefits of the site. Join Now and plug into the Science|Business Network to get full access to all our news, events and business opportunities.
Science|Business is the first independent media company that brings together researchers, investors and policy makers in the European innovation community. It does so with a top-quality team and unique network of Europe's leading scientific institutions, corporations, policy makers and IP and VC specialists.
Be where innovation begins – become a member. Click here to learn more.